117 related articles for article (PubMed ID: 16241960)
1. Role of angiotensin-converting enzyme insertion/deletion and plasminogen activator inhibitor-1 4G/5G gene polymorphisms in retinal vein occlusion.
Mattes D; Weger M; Renner W; Cichocki L; Haas A
J Thromb Haemost; 2005 Nov; 3(11):2583-4. PubMed ID: 16241960
[No Abstract] [Full Text] [Related]
2. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes.
Margaglione M; Grandone E; Vecchione G; Cappucci G; Giuliani N; Colaizzo D; Celentano E; Panico S; Di Minno G
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2082-7. PubMed ID: 9351375
[TBL] [Abstract][Full Text] [Related]
3. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
Kuhli-Hattenbach C; Hellstern P; Nägler DK; Kohnen T; Hattenbach LO
Ophthalmic Genet; 2017; 38(5):413-417. PubMed ID: 28085526
[TBL] [Abstract][Full Text] [Related]
4. Genotype combinations of plasminogen activator inhibitor-1 and angiotensin-converting enzyme genes and risk for early onset of coronary heart disease.
Loew M; Hoffmann MM; Hahmann H; Maerz W; Brenner H; Rothenbacher D
Eur J Cardiovasc Prev Rehabil; 2006 Jun; 13(3):449-56. PubMed ID: 16926677
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome.
Sun L; Lv H; Wei W; Zhang D; Guan Y
J Endocrinol Invest; 2010 Feb; 33(2):77-82. PubMed ID: 19636212
[TBL] [Abstract][Full Text] [Related]
6. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms associated with retinal vein occlusion: a Greek case-control study and meta-analysis.
Yioti GG; Panagiotou OA; Vartholomatos GA; Kolaitis NI; Pappa CN; Evangelou E; Stefaniotou MI
Ophthalmic Genet; 2013 Sep; 34(3):130-9. PubMed ID: 23289804
[TBL] [Abstract][Full Text] [Related]
8. Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels.
Gori AM; Marcucci R; Fatini C; Gensini F; Sticchi E; Sodi A; Cappelli S; Menchini U; Gensini GF; Abbate R; Prisco D
Thromb Haemost; 2004 Jul; 92(1):54-60. PubMed ID: 15213845
[TBL] [Abstract][Full Text] [Related]
9. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
Nowakowska A
Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M
Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism and synergism of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) genes in coronary artery disease.
Sakhteh M; Poopak B; Amirizadeh N; Shamshiri A; Bagheri A; Faranoush M
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1168-74. PubMed ID: 25501306
[TBL] [Abstract][Full Text] [Related]
12. [The investigation of angiotensin converting enzyme I/D and plasminogen activator inhibitor-1 4G/5G polymorphisms in venous thromboembolism patients].
Kaya H; Karkucak M; Salifoğlu H; Torun D; Kozan S; Tunca Y
Tuberk Toraks; 2013; 61(2):88-95. PubMed ID: 23875585
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients.
Prisco D; Fatini C; Battaglini B; Gensini F; Fedi S; Falai M; Chioccioli M; Gori AM; Margheri M; Gensini GF
Int J Clin Lab Res; 2000; 30(4):179-85. PubMed ID: 11289708
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor-1 and angiotensin converting enzyme gene polymorphisms in Turkish asthmatic children.
Bora E; Soylar R; Arıkan-Ayyıldız Z; Uzuner N; Giray-Bozkaya Ö; Erçal D; Karaman Ö; Ülgenalp A
Allergol Immunopathol (Madr); 2013; 41(1):11-6. PubMed ID: 22361338
[TBL] [Abstract][Full Text] [Related]
15. The relationship between plasma t-PA and PAI-1 levels is dependent on epistatic effects of the ACE I/D and PAI-1 4G/5G polymorphisms.
Moore JH; Smolkin ME; Lamb JM; Brown NJ; Vaughan DE
Clin Genet; 2002 Jul; 62(1):53-9. PubMed ID: 12123488
[TBL] [Abstract][Full Text] [Related]
16. Insertion/deletion plasminogen activator inhibitor 1 and insertion/deletion angiotensin-converting enzyme gene polymorphisms in diabetic retinopathy in type 2 diabetes.
Globocnik-Petrovic M; Hawlina M; Peterlin B; Petrovic D
Ophthalmologica; 2003; 217(3):219-24. PubMed ID: 12660488
[TBL] [Abstract][Full Text] [Related]
17. Combinations of fibrinolytic gene polymorphisms (plasminogen activator inhibitor type 1 4G/5G, factor XIII Val34Leu and angiotensin-converting enzyme I/D) in women with idiopathic infertility.
Velickovic J; Jelicic M; Stojkovic O
Blood Coagul Fibrinolysis; 2021 Mar; 32(2):103-107. PubMed ID: 33555692
[TBL] [Abstract][Full Text] [Related]
18. PAI-1 4G/5G and ACE I/D gene polymorphisms and the occurrence of myocardial infarction in patients on intermittent dialysis.
Aucella F; Margaglione M; Vigilante M; Gatta G; Grandone E; Forcella M; Ktena M; De Min A; Salatino G; Procaccini DA; Stallone C
Nephrol Dial Transplant; 2003 Jun; 18(6):1142-6. PubMed ID: 12748347
[TBL] [Abstract][Full Text] [Related]
19. The PAI-1 4G/5G and ACE I/D polymorphisms and risk of recurrent pregnancy loss: a case-control study.
Kim JJ; Choi YM; Lee SK; Yang KM; Paik EC; Jeong HJ; Jun JK; Han AR; Hong MA
Am J Reprod Immunol; 2014 Dec; 72(6):571-6. PubMed ID: 25078885
[TBL] [Abstract][Full Text] [Related]
20. Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients.
Wong TY; Poon P; Szeto CC; Chan JC; Li PK
Kidney Int; 2000 Feb; 57(2):632-8. PubMed ID: 10652041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
